Evidence map›Paper›PMID 38418708›Full record

ArticleActa neuropathologica2024

Astroglial calcium signaling and homeostasis in tuberous sclerosis complex.

Alessia Romagnolo, Giulia Dematteis, Mirte Scheper, Mark J Luinenburg, Angelika Mühlebner, Wim Van Hecke, Marcello Manfredi, Veronica De Giorgis, Simone Reano, Nicoletta Filigheddu and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Alessia Romagnolo *Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands. a.romagnolo@amsterdamumc.nl.ORCID 0000-0001-5357-0961
Giulia Dematteis *Department of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy.
Mirte ScheperDepartment of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Mark J LuinenburgDepartment of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Angelika MühlebnerDepartment of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Wim Van HeckeDepartment of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
Marcello ManfrediCenter on Autoimmune and Allergic Diseases (CAAD), UPO, Novara, Italy.
Veronica De GiorgisCenter on Autoimmune and Allergic Diseases (CAAD), UPO, Novara, Italy.
Simone ReanoCenter on Autoimmune and Allergic Diseases (CAAD), UPO, Novara, Italy.
Nicoletta FilighedduDepartment of Translational Medicine, UPO, Novara, Italy.
Valeria BortolottoDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy.
Laura TapellaDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy.
Jasper J AninkDepartment of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Liesbeth FrançoisNeurosciences Therapeutic Area, UCB Pharma, Braine-L'Alleud, Belgium.
Stefanie DedeurwaerdereNeurosciences Therapeutic Area, UCB Pharma, Braine-L'Alleud, Belgium.
James D MillsDepartment of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Armando A GenazzaniDepartment of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy.
Dmitry Lim *Department of Pharmaceutical Sciences, Università del Piemonte Orientale "Amedeo Avogadro", Novara, Italy.
Eleonora Aronica *Department of (Neuro) Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Amsterdam Neuroscience · NLUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUCB Pharma (Belgium) · BEUniversity Medical Center Utrecht · NLEpilepsy Research UK · GB

Funding

H2020 European Research Council 952455Stichting Epilepsie Instellingen Nederland 20-02
6 · The paper itself

Abstract

Tuberous Sclerosis Complex (TSC) is a multisystem genetic disorder characterized by the development of benign tumors in various organs, including the brain, and is often accompanied by epilepsy, neurodevelopmental comorbidities including intellectual disability and autism. A key hallmark of TSC is the hyperactivation of the mechanistic target of rapamycin (mTOR) signaling pathway, which induces alterations in cortical development and metabolic processes in astrocytes, among other cellular functions. These changes could modulate seizure susceptibility, contributing to the progression of epilepsy and its associated comorbidities. Epilepsy is characterized by dysregulation of calcium (Ca

Indexed as

EpilepsyTuberous SclerosisAstrocytesCalciumCalcium SignalingHomeostasisHumansSeizuresTOR Serine-Threonine KinasesCalciumTOR Serine-Threonine KinasesAstrocytesCalcium signalingEpilepsyMitochondriamTORTuberous sclerosis complex

Identifiers

PMID38418708
PMCPMC10901927
OpenAlexW4392230613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.